vs

Side-by-side financial comparison of Clearfield, Inc. (CLFD) and Medirom Healthcare Technologies Inc. (MRM). Click either name above to swap in a different company.

Clearfield, Inc. is the larger business by last-quarter revenue ($34.3M vs $21.1M, roughly 1.6× Medirom Healthcare Technologies Inc.). Clearfield, Inc. runs the higher net margin — -1.8% vs -21.3%, a 19.5% gap on every dollar of revenue. Medirom Healthcare Technologies Inc. produced more free cash flow last quarter ($-2.4K vs $-2.4M).

Clearfield, Inc. is a company headquartered in Minneapolis, Minnesota. The company produces fiber optic products.

Medirom Healthcare Technologies Inc. develops and delivers integrated digital health and remote patient monitoring solutions targeted at chronic disease management, post-operative care, and senior health support. It serves healthcare providers, insurance payers, and institutional care partners across key markets in North America and the Asia-Pacific region, prioritizing accessible, data-driven care to improve patient outcomes.

CLFD vs MRM — Head-to-Head

Bigger by revenue
CLFD
CLFD
1.6× larger
CLFD
$34.3M
$21.1M
MRM
Higher net margin
CLFD
CLFD
19.5% more per $
CLFD
-1.8%
-21.3%
MRM
More free cash flow
MRM
MRM
$2.4M more FCF
MRM
$-2.4K
$-2.4M
CLFD

Income Statement — Q1 FY2026 vs Q2 FY2025

Metric
CLFD
CLFD
MRM
MRM
Revenue
$34.3M
$21.1M
Net Profit
$-614.0K
$-4.5M
Gross Margin
33.2%
10.8%
Operating Margin
-5.3%
-28.5%
Net Margin
-1.8%
-21.3%
Revenue YoY
-3.2%
Net Profit YoY
67.8%
EPS (diluted)
$-0.04

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLFD
CLFD
MRM
MRM
Q4 25
$34.3M
Q3 25
$23.4M
Q2 25
$49.9M
$21.1M
Q1 25
$47.2M
Q4 24
$29.7M
Q3 24
$5.6M
Q2 24
$48.8M
Q1 24
$36.9M
Net Profit
CLFD
CLFD
MRM
MRM
Q4 25
$-614.0K
Q3 25
$-9.1M
Q2 25
$1.6M
$-4.5M
Q1 25
$1.3M
Q4 24
$-1.9M
Q3 24
Q2 24
$-447.0K
Q1 24
$-5.9M
Gross Margin
CLFD
CLFD
MRM
MRM
Q4 25
33.2%
Q3 25
53.2%
Q2 25
30.5%
10.8%
Q1 25
30.1%
Q4 24
29.2%
Q3 24
Q2 24
21.9%
Q1 24
7.7%
Operating Margin
CLFD
CLFD
MRM
MRM
Q4 25
-5.3%
Q3 25
10.3%
Q2 25
3.0%
-28.5%
Q1 25
0.6%
Q4 24
-6.9%
Q3 24
Q2 24
-4.7%
Q1 24
-26.4%
Net Margin
CLFD
CLFD
MRM
MRM
Q4 25
-1.8%
Q3 25
-38.8%
Q2 25
3.2%
-21.3%
Q1 25
2.8%
Q4 24
-6.4%
Q3 24
Q2 24
-0.9%
Q1 24
-16.0%
EPS (diluted)
CLFD
CLFD
MRM
MRM
Q4 25
$-0.04
Q3 25
$-0.65
Q2 25
$0.11
Q1 25
$0.09
Q4 24
$-0.13
Q3 24
Q2 24
$-0.04
Q1 24
$-0.40

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLFD
CLFD
MRM
MRM
Cash + ST InvestmentsLiquidity on hand
$96.4M
$252.3K
Total DebtLower is stronger
$8.8M
Stockholders' EquityBook value
$249.7M
$1.6M
Total Assets
$268.1M
$52.0M
Debt / EquityLower = less leverage
5.55×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLFD
CLFD
MRM
MRM
Q4 25
$96.4M
Q3 25
$106.0M
Q2 25
$117.2M
$252.3K
Q1 25
$112.0M
Q4 24
$113.0M
Q3 24
$129.0M
Q2 24
$123.8M
Q1 24
$142.9M
Total Debt
CLFD
CLFD
MRM
MRM
Q4 25
Q3 25
Q2 25
$8.8M
Q1 25
Q4 24
Q3 24
$2.2M
Q2 24
$2.1M
Q1 24
Stockholders' Equity
CLFD
CLFD
MRM
MRM
Q4 25
$249.7M
Q3 25
$256.2M
Q2 25
$264.5M
$1.6M
Q1 25
$265.9M
Q4 24
$267.4M
Q3 24
$275.8M
Q2 24
$274.6M
Q1 24
$279.2M
Total Assets
CLFD
CLFD
MRM
MRM
Q4 25
$268.1M
Q3 25
$306.2M
Q2 25
$314.7M
$52.0M
Q1 25
$310.9M
Q4 24
$303.2M
Q3 24
$315.3M
Q2 24
$318.1M
Q1 24
$315.4M
Debt / Equity
CLFD
CLFD
MRM
MRM
Q4 25
Q3 25
Q2 25
5.55×
Q1 25
Q4 24
Q3 24
0.01×
Q2 24
0.01×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLFD
CLFD
MRM
MRM
Operating Cash FlowLast quarter
$-1.4M
$-2.3K
Free Cash FlowOCF − Capex
$-2.4M
$-2.4K
FCF MarginFCF / Revenue
-7.1%
-0.0%
Capex IntensityCapex / Revenue
2.9%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLFD
CLFD
MRM
MRM
Q4 25
$-1.4M
Q3 25
Q2 25
$7.9M
$-2.3K
Q1 25
$3.0M
Q4 24
$7.2M
Q3 24
$22.2M
Q2 24
$4.0M
Q1 24
$-5.7M
Free Cash Flow
CLFD
CLFD
MRM
MRM
Q4 25
$-2.4M
Q3 25
Q2 25
$7.5M
$-2.4K
Q1 25
$654.0K
Q4 24
$5.1M
Q3 24
$18.2M
Q2 24
$2.8M
Q1 24
$-7.7M
FCF Margin
CLFD
CLFD
MRM
MRM
Q4 25
-7.1%
Q3 25
Q2 25
15.1%
-0.0%
Q1 25
1.4%
Q4 24
17.1%
Q3 24
323.0%
Q2 24
5.8%
Q1 24
-20.8%
Capex Intensity
CLFD
CLFD
MRM
MRM
Q4 25
2.9%
Q3 25
2.0%
Q2 25
0.8%
0.0%
Q1 25
5.1%
Q4 24
7.0%
Q3 24
71.4%
Q2 24
2.5%
Q1 24
5.3%
Cash Conversion
CLFD
CLFD
MRM
MRM
Q4 25
Q3 25
Q2 25
4.93×
Q1 25
2.30×
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLFD
CLFD

Segment breakdown not available.

MRM
MRM

Professional services expense$20.0M95%
Other$1.1M5%

Related Comparisons